Potantial utility of disulfiram against leishmaniasis.
Namazi
M R
MR
D018435:ATP Binding Cassette Transporter, Subfamily B / Q000378:metabolism; D000276:Adjuvants, Immunologic / Q000494:pharmacology; D000818:Animals; D002614:Chelating Agents / Q000494:pharmacology; D004221:Disulfiram / Q000494:pharmacology*; D004050:Ditiocarb / Q000494:pharmacology; D004351:Drug Resistance; D005978:Glutathione / Q000378:metabolism; D006801:Humans; D007893:Leishmania donovani / Q000378:metabolism; D018320:Leishmania major / Q000378:metabolism; D007895:Leishmania tropica / Q000378:metabolism; D007896:Leishmaniasis / Q000188:drug therapy*; D009569:Nitric Oxide / Q000378:metabolism; D018384:Oxidative Stress
D018435:ATP Binding Cassette Transporter, Subfamily B; D000276:Adjuvants, Immunologic; D002614:Chelating Agents; D009569:Nitric Oxide; D004050:Ditiocarb; D005978:Glutathione; D004221:Disulfiram